We found that the immunomodulator TGFBR1 showed positive correlation with TPM1 expression in colon cancer (Figure 7c), and the immunomodulator TNFRSF25 showed negative correlation with TPM1 (Figure 7d). Here, TGFBR1 is linked to colonic neoplasm.